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ABSTRACT
Spontaneous regression (SR) of cancer, especially lung cancer, is a rare biological event with a mechanism that is not 
currently understood. Immunological mechanisms seem to be the stronger explanation in SR of a lung cancer. We report 
the rare case of SR of a lung adenocarcinoma stage IA, in a 75-year-old man, which was incidentally diagnosed and 
histologically confirmed. Due to the patient’s comorbidities and his poor pulmonary function, stereotactic radiotherapy 
was scheduled. However, by the time the treatment was due to start, the tumor was no longer detectable. 
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Our patient was a 75-year-old Caucasian 
man with a medical history of heavy smoking, 
obstructive pulmonary disease, sleep apnea, arterial 
hypertension, infra-renal aortic aneurism, cardiac 
failure, endarterectomy of the ascending aorta, and 
aortic valve substitution.
He underwent a surveillance thoracoabdominal 
computed tomography (CT) scan 3 years ago that 
showed a suspicious 19 mm nodule in the right 
superior lobe (Figure 1), which was investigated by 
a transthoracic core biopsy. The pathology report 
revealed an adenocarcinoma with tubular pattern and 
same mucosecretory cells. The immunohistochemistry 
study with TTF1 was positive in neoplastic cells, to 
confirm the pulmonary origin of the adenocarcinoma 
(Figures 2A and 2B). A positron emission tomography 
(PET)-CT was performed and showed no other sites 
of radiotracer uptake, besides the pulmonary nodule 
(Figure 3) rendering the cT1N0M0 as stage IA.
The patient then underwent pulmonary function 
tests that disclosed he was not a candidate for surgery 
(forced vital capacity [FVC]: 93.7%; forced expiratory 
volume in the first second [FEV1]: 40.9%; FEV 1/FVC 
ratio: 32.93%; and diffusion capacity of the lungs for 
carbon monoxide [DLCO]: 39.3%).
The case was analyzed in a multidisciplinary 
meet ing,  and was dec ided that  s tereotact ic 
radiotherapy, would be the most appropriate 
treatment, because of his comorbidities and poor 
pulmonary function.
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Three months after the core biopsy and 1 month 
after PET-CT, a planning CT scan before starting 
radiotherapy was conducted and the nodule was no 
longer seen. During this period, the patient didn’t have 
any infection, or started any new medication, namely 
systemic corticosteroid, or other immunosuppression. 
We performed sequential CT and PET-CT, which 
confirmed that the tumor had indeed disappeared 
(Figures 4 and 5). The histology was reviewed and 
the pathologist confirmed the diagnosis of lung 
adenocarcinoma.
Figure 2. Microphotography of the lung biopsy. A – Acinar adenocarcinoma, with moderate pleomorphism 
(H&E, 200X); B – Positivity for TTF-1 (100X).
Figure 1. Chest computed tomography scan revealing 
an irregular 19 mm nodule in the right superior lobe.
The patient is currently undergoing regular 
follow-up examinations at this hospital, and has not 
shown any evidence of disease for the past 3 years.
This manuscript is in accordance with the 
institutional ethics committee, and the patient signed 
an informed consent.
DISCUSSION
Spontaneous regression (SR) of a cancer is defined 
as total or partial disappearance without treatment or 
in the presence of a known inappropriate/ineffective 
treatment in oncological diseases.1
This phenomenon is rare, but possible, and it has 
been found in several cases described in the literature. 
Everson and Cole,2 and Cole,3 reported 176 cases of 
SR from 1900 to 1964, with an estimated incidence of 
1 out of 60,000-100,000 people with cancer.
The  tumors  in  wh ich  th i s  phenomenon 
is most frequently described are kidney cancer, 
neuroblastomas, and lymphomas.3 Currently, there 
are 17 well-documented case reports of lung cancer 
with SR (10 non-small cell lung cancer and 7 small cell 
lung cancer) (Table 1).4-20
The exact mechanisms of the SR are unknown, 
but there are several hypotheses described in the 
literature; namely (i) immunological mechanisms; 
(ii) the existence of SR after a serious local infection; 
(iii) the suspension of immunosuppression therapy; 
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Figure 3. Chest positron emission tomography-computed tomography (PET-CT) (5 months after first CT, 3 months 
after biopsy). A – Axial CT acquisition; B – Increased 18F-deoxyglucose (FDG) uptake in the right superior lobe 
(standardized uptake value max = 6.8) without other FDG captation.
Figure 4. Chest computed tomography (CT). A – Six months after first CT and 4 months after the biopsy; note the 
vanishing of the right superior lobe 19 mm nodule; B – Absence of the nodule relapse 3 years after the diagnosis.
Figure 5. Chest positron emission tomography-computed tomography (PET-CT) performed 1 year after diagnosis. 
A – CT axial image acquisition; B – Absence of 18F-deoxyglucose captation.
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Table 1. Spontaneous remission of lung cancer proven in histological examinations: review of the literature
Reference Sex/Age and Histology Possible Factors Related to SR
Menon & Eaton4 
United States
Male/44
Non-small cell lung cancer SR after immune reconstitution in a patient with HIV
Inui et al.5 
Japan
Female/69
Small cell lung cancer No mechanisms of SR proposed
Lopez-Pastorini et al.6
Germany
Male/76
Large cell lung cancer Immune response after biopsy
Kitai et al.7 
Japan
Female/65
Small cell lung cancer
Anti-tumor immunity against recovering might have resulted in SR 
in this case
Choi et al.8 
Korea
Male/71
Squamous cell carcinoma Tuberculosis might have stimulated the immune system
Furukawa et al.9 
Japan
Male/56
Squamous cell carcinoma
Bullous wall deformation and the generation of phlegm might have 
led to the reduction in tumor size
Mizuno et al.10 
Japan
Male/62
Large cell carcinoma
A transformed clone resistant to previous immunity might have 
developed.
Surgical intervention might have suppressed the patient’s immunity 
against a microscopic adrenal viable tumor, and accelerated tumor 
progression
Gladwish et al.11 
Canada
Female/81
Squamous cell carcinoma
Psychoneuroimmunological mechanisms
Alternative herbal remedy, Essiac
Mawhinney et al.12
United Kingdom
Female/83
Small-cell lung cancer
The association between the paraneoplastic syndrome and 
spontaneous tumor regression is strongly suggestive that an 
anti-tumor immune-mediated response is the underlying mechanism
Nakamura et al.13
Japan
Male/71
Adenocarcinoma
Systemic immunity against NY-ESO-1 contributed to the tumor 
regression in this case
Agarwal et al.14
India
Male/70
Small-cell lung cancer No mechanisms of SR proposed
Lee et al.15
Korea
Female/70
Small-cell lung cancer SR was likely to be attributable to infection immune activation
Hirano et al.16 
Japan
Female/55
Small-cell lung cancer
Anti-neuronal antibody may react with both tumor and nervous 
tissue
Pujol et al.17 
France
Female/75
Squamous cell carcinoma
The immunology of anti-Hu paraneoplastic syndrome by itself could 
induce tumor response
Horino et al.18 
Japan
Male/ 86
Small-cell lung cancer Paraneoplastic sensory neuronopathy
Cafferata et al.19 
Italy
Male/68
Adenocarcinoma No mechanisms of SR proposed
Kappauf et al.20
Germany
Male/61
Adenocarcinoma No mechanisms of SR proposed
SR = spontaneous regression.
(iv) immune reconstitution in HIV patients; and 
(v) paraneoplastic syndrome.21
Other possibly related factors described in the 
literature are: hormonal mechanisms; tumor necrosis; 
destruction of the tumor feeding artery during the 
biopsy; angiogenesis and telomerase inhibition; 
increased apoptosis; psycho-neurological factors; 
suspension of exogenous carcinogens; and the 
differentiation of malignant cells into benign ones.3,22
In this case, we did not find any certain mechanism 
of SR among those already described.
One possible explanation could be the destruction 
or emboli of the feeding artery of the tumor by the 
core needle biopsy. Another theory might be that the 
injury caused by this procedure could somehow elicit 
an inflammatory response or even release antigens 
that were hidden, with a consequent activation of the 
immune system.
Desp i te  the  absence  of  ev idence  of  an 
immunological mechanism, such as paraneoplastic 
syndrome or an infection, we believe that the main 
mechanism in this patient’s case was probably his 
immune system activated by the needle core biopsy. 
Corroborating with this hypothesis is the recognition 
of lung cancer as an immunogenic tumor, especially 
in heavy smoking patients, which has been associated 
with response to immunotherapy (anti-PD1/PD-L1) and 
a higher neoantigen burden.5
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CONCLUSION
The SR of  a cancer  i s  poss ib le ,  and is  a 
well-documented phenomenon in the literature. 
The mechanism of this event remains a mystery, and 
further research is essential to fully comprehend this 
unusual phenomenon.
In this case, the immune system of the patient 
activated by the needle core biopsy seems to be an 
important mechanism of SR.
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